Co-founder & Director Leucine Rich Bio
We plan to expand product portfolio , export to other Asian nations in 2024
Debojyoti Dhar
Co-founder & Director Leucine Rich Bio
We plan to expand product portfolio , export to other Asian nations in 2024
In 2023 , there was a notable rise in awareness among people regarding the importance of gut health and its correlation with overall well-being . This year was significant for us as we added more feathers to our cap . We launched the nutraceutical brand called Rychbiome , with its first product being Rychbiome Indus : a synbiotic ( combination of pre and probiotics ) derived from the Indian gut microbiota data . In addition , we achieved a major milestone by establishing a one-of-itskind gut health clinic in Bengaluru that provides holistic healthcare solutions for people with health conditions like diabetes and obesity . We also started the export of our gut microbiome test kit , BugSpeaks , to the Philippines . Moreover , we completed a clinical trial on BugSpeaks and anticipate its data to be published very soon .
In the coming year , we aim to export BugSpeaks to other Asian countries . We are also going to expand our product portfolio by coming up with novel solutions addressing the healthcare needs of the Indian population .
BIOVOICENEWS . COM 39